SuperworthImmunocore market cap IMCR
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $1.6B
- Highest close in our data
- $3.6B
- Feb 2024
Immunocore is worth $1.6B at the close on Oct 23, 2026, at $30.98 a share.
That is down 4% over the last year and up 30% over five years.
Its highest close in our data was $3.6B in Feb 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.6B | $1.4B | $1.9B | −13% |
| 2025 | $1.8B | $1.3B | $2B | +25% |
| 2024 | $1.5B | $1.4B | $3.6B | −56% |
| 2023 | $3.3B | $2.1B | $3.3B | +31% |
| 2022 | $2.5B | $630.3M | $2.8B | +130% |
| 2021 | $1.1B | $889.3M | $1.3B | n/a |
Against its peers
Companies in Biotechnology nearest Immunocore's size, closest first, today.
| Company | Market cap |
|---|---|
| IMCRImmunocore | $1.6B |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| MGTXMeiraGTx | $884.6M |
| KRYSKrystal Biotech | $9.2B |
| RGENRepligen | $10B |
| TECHBIO-TECHNE | $11.4B |
| PLXProtalix BioTherapeutics | $205.5M |
| HALOHalozyme Therapeutics | $14.3B |
| NBIXNeurocrine Biosciences | $14.5B |
| Peer median | $9.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Immunocore
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.